Literature DB >> 35939146

Murine macrophages do not support the proliferation of Leishmania (Viannia) braziliensis amastigotes even in absence of nitric oxide and presence of high arginase activity.

Mirian Vieira Teixeira1, Santiago Aguiar Espellet Soares1, Vagniton Amélio Souza1, André Murilo de Souza Marques1, Celia Maria de Almeida Soares2, Lilian Cristiane Baeza3, Milton Adriano Pelli de Oliveira4.   

Abstract

Leishmania (Viannia) braziliensis is the main species responsible for American tegumentary leishmaniasis in Brazil. Nevertheless, the use of this parasite species to study Leishmania infection in the murine model has been less conducted when compared with other Leishmania species. The control of murine infection with Leishmania has been associated with nitric oxide (NO) produced by inducible NO synthase (iNOS) from M1 macrophages, while arginase expressed by M2 macrophages is related to Leishmania proliferation. Here we use three different strains of L. (V.) braziliensis and one strain of L. (L.) major to study a 9-day infection of macrophages in vitro. Wild-type bone marrow-derived macrophages (BMDM) supported the proliferation of L. (L) major amastigotes from the 3rd day after infection, while all strains of L. (V.) braziliensis did not proliferate even inside IL-4-treated or iNOS knockout (KO) macrophages. The arginase activity was higher in iNOS KO than IL-4-treated macrophage showing that the absence of proliferation is independent of arginase. Importantly, L. (V.) braziliensis was able to cause uncontrolled disease in iNOS KO mice in vivo demonstrating that murine macrophages present at the site of infection have additional changes beyond inhibition of NO production or stimulation of arginase activity to support parasite proliferation.
© 2022. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Entities:  

Keywords:  Amastigote proliferation; In vitro infection; Leishmania braziliensis; Leishmania major

Mesh:

Substances:

Year:  2022        PMID: 35939146     DOI: 10.1007/s00436-022-07614-4

Source DB:  PubMed          Journal:  Parasitol Res        ISSN: 0932-0113            Impact factor:   2.383


  25 in total

1.  Leishmania major amastigotes initiate the L-arginine-dependent killing mechanism in IFN-gamma-stimulated macrophages by induction of tumor necrosis factor-alpha.

Authors:  S J Green; R M Crawford; J T Hockmeyer; M S Meltzer; C A Nacy
Journal:  J Immunol       Date:  1990-12-15       Impact factor: 5.422

2.  Th1-Th2 Cross-Regulation Controls Early Leishmania Infection in the Skin by Modulating the Size of the Permissive Monocytic Host Cell Reservoir.

Authors:  Matheus Batista Carneiro; Mateus Eustáquio Lopes; Leah S Hohman; Audrey Romano; Bruna Araujo David; Rachel Kratofil; Paul Kubes; Matthew L Workentine; Alexandre C Campos; Leda Quercia Vieira; Nathan C Peters
Journal:  Cell Host Microbe       Date:  2020-04-15       Impact factor: 21.023

3.  Leishmania (Viannia) braziliensis amastigotes from patients with mucosal leishmaniasis have increased ability to disseminate and are controlled by nitric oxide at the early stage of murine infection.

Authors:  Clayson M Gomes; Lucilla R Ávila; Jéssica C Santos; Pollyana G Oliveira; Fernanda D Tomé; Ledice I A Pereira; Miriam L Dorta; Ruy S Lino; Fátima Ribeiro-Dias; Milton A P Oliveira
Journal:  Pathog Dis       Date:  2016-04-11       Impact factor: 3.166

Review 4.  Regulation of macrophage subsets and cytokine production in leishmaniasis.

Authors:  M B Carneiro; L G Vaz; L C C Afonso; M F Horta; L Q Vieira
Journal:  Cytokine       Date:  2020-12-14       Impact factor: 3.861

5.  BALB/c mice infected with antimony treatment refractory isolate of Leishmania braziliensis present severe lesions due to IL-4 production.

Authors:  Diego L Costa; Vanessa Carregaro; Djalma S Lima-Júnior; Neide M Silva; Cristiane M Milanezi; Cristina R Cardoso; Ângela Giudice; Amélia R de Jesus; Edgar M Carvalho; Roque P Almeida; João S Silva
Journal:  PLoS Negl Trop Dis       Date:  2011-03-01

Review 6.  Macrophage Metabolism As Therapeutic Target for Cancer, Atherosclerosis, and Obesity.

Authors:  Xenia Geeraerts; Evangelia Bolli; Sarah-Maria Fendt; Jo A Van Ginderachter
Journal:  Front Immunol       Date:  2017-03-15       Impact factor: 7.561

Review 7.  Purinergic signaling and infection by Leishmania: A new approach to evasion of the immune response.

Authors:  Amanda Braga de Figueiredo; Miriam Conceicao Souza-Testasicca; Luis Carlos Crocco Afonso
Journal:  Biomed J       Date:  2016-09-21       Impact factor: 4.910

8.  Macrophages as host, effector and immunoregulatory cells in leishmaniasis: Impact of tissue micro-environment and metabolism.

Authors:  Christian Bogdan
Journal:  Cytokine X       Date:  2020-10-12

9.  T helper1/t helper2 cells and resistance/susceptibility to leishmania infection: is this paradigm still relevant?

Authors:  James Alexander; Frank Brombacher
Journal:  Front Immunol       Date:  2012-04-17       Impact factor: 7.561

10.  CD11c-expressing Ly6C+CCR2+ monocytes constitute a reservoir for efficient Leishmania proliferation and cell-to-cell transmission.

Authors:  Sandrina Heyde; Lars Philipsen; Pauline Formaglio; Yan Fu; Iris Baars; Guido Höbbel; Corinna L Kleinholz; Elena A Seiß; Juliane Stettin; Patricia Gintschel; Anne Dudeck; Philippe Bousso; Burkhart Schraven; Andreas J Müller
Journal:  PLoS Pathog       Date:  2018-10-22       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.